Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science 460 pages Hardcover: 978-09734676-5-9 Softcover: 978-09734676-6-6 Third Edition August, 2008 Homepage The […]
Building Biotechnology 3rd Edition now available Read Post »
Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to
Beyond the Business Plan: Managing unexpected risk in biotechnology business development Read Post »
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech's mating dance — This isn't the first time Read Post »
Roche has floated an offer to acquire Genentech, a move which has raised a flurry of questions about the sustainability
Roche and Genentech’s mating dance — This isn’t the first time Read Post »
Guest content from Christopher Starr: After years of confusion and neglect, translational research is now becoming institutionalized. Citing the barriers
Background: The Clinical and Translational Science Awards Consortium (CTSA program) Read Post »
Guest content from Nicolaj H. Nielsen, managing director of Biostrat. A case-study on the recent licensing-deal between Myriad and Lundbeck:
Reach a targeted audience with BiotechBlog. Advertising opportunities are available on BiotechBlog. BiotechBlog is syndicated by BlogBurst, which means that
The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and
Looking for writers for two book projects: 1) Convert a 102 page screenplay into a book. The topic is the
After an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted
Get new actionable insights and updates from BiotechBlog
